A rare homozygous variant of CHKB induced severe cardiomyopathy and a cardiac conduction disorder: a case report
This study expands the spectrum of <i>CHKB</i> mutations and provides essential information for the genotype-phenotype map of a nonsense variant of the gene. It is important to confirm a differential diagnosis among such patients using WES analyses. Regular cardiac and musculoskeletal monitoring is recommended for MCMD patients. Patients with a CHKB deficiency presenting with heart blocks could benefit from the administration of cardiac resynchronization therapy. This therapeutic approach might improve cardiac function and conduction in patients with CHKB-related cardiomyopathies.
Authors
- Hongyu Duan (ORCID: https://orcid.org/0000-0001-6650-519X)
- Siyuan Jing
- Lu Liu (ORCID: https://orcid.org/0000-0002-4452-3079)
- Fuqiang Liu
- Yimin Hua (ORCID: https://orcid.org/0000-0001-9331-7653)
- Yifei Li
Institutions
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2024-10-11
- DOI
- https://doi.org/10.3389/fcvm.2024.1469237
- Citations
- 1
- Primary Topic
- Ubiquitin and proteasome pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.23
Funders
- National Natural Science Foundation of China